Psoriasis and metabolic syndrome
Open Access
- 31 October 2011
- journal article
- review article
- Published by Wiley in The Journal of Dermatology
- Vol. 39 (3), 212-218
- https://doi.org/10.1111/j.1346-8138.2011.01408.x
Abstract
Psoriasis is a chronic inflammatory and immune‐mediated disease associated with several comorbidities, such as obesity, hypertension, diabetes mellitus, dyslipidemia and cardiovascular disorder. These comorbidities are components of metabolic syndrome. The pathogenesis of metabolic syndrome is supposed to be related to increased levels of adipocytokines, such as tumor necrosis factor‐α (TNF‐α) and adiponectin. Recent study has revealed a high prevalence of metabolic syndrome in psoriatics compared with other skin diseases. Biologic agents, including anti‐TNF‐α antibodies, are recommended as the first‐line treatment for psoriatics with metabolic syndrome. This article reviews the association of psoriasis and metabolic syndrome in terms of adipocytokines and evaluates the role of biologic agents in the treatment of psoriasis.Keywords
This publication has 94 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome in PsoriasisArchives of Dermatology, 2011
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Effects of Etanercept in Patients With the Metabolic SyndromeArchives of Internal Medicine, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- Psoriasis is associated with lipid abnormalities at the onset of skin diseaseJournal of the American Academy of Dermatology, 2006
- Plasma leptin is independently associated with the intima-media thickness of the common carotid arteryInternational Journal of Obesity, 2001
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995